Events2Join

Emerging biomarkers in the detection and prognosis of prostate ...


Emerging biomarkers in the detection and prognosis of prostate ...

The prostate-specific antigen (PSA) is currently the most used tumor marker in the early detection of the prostate cancer (PCa), despite its low specificity ...

Emerging biomarkers in the diagnosis of prostate cancer - PMC

Prostate-specific antigen (PSA) remains the most used test to detect PCa. Its limited specificity and an elevated rate of overdiagnosis are the ...

Emerging Biomarkers for the Diagnosis and Prognosis of Prostate ...

The biomarker currently used for CaP diagnosis is prostate-specific antigen (PSA). It is considered both the best tumor marker available for any ...

Emerging Biomarkers for the Diagnosis and Prognosis of Prostate ...

These markers include kallikrein-related peptidase 2 (KLK2), early prostate cancer antigen (EPCA), PCA3, hepsin, prostate stem cell antigen, and α-methylacyl- ...

Emerging biomarkers in the detection and prognosis of prostate ...

The prostate-specific antigen (PSA) is currently the most used tumor marker in the early detection of the prostate cancer (PCa), ...

New generation biomarkers for the detection of prostate cancer

One of the most promising early symptomatic tools for tracking infection spread and subsequent disease treatment is biomarker-based malignant growth screening.

The promising role of new molecular biomarkers in prostate cancer

We analyze several aspects that are relevant for prostate cancer including its new molecular markers associated with diagnosis, prognosis, and ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

Studies have shown that those urine biomarkers outperform PSA as a diagnostic and, more importantly, prognostic biomarker. All tests have a high negative ...

Current and emerging tissue‐based molecular biomarkers for ...

The aim of this review is to discuss and evaluate prostate cancer tissue-based biomarkers that have been developed to aid diagnosis, improve risk ...

Advances in Prostate Cancer Biomarkers and Probes

Early diagnosis of PCa is essential to improve the survival rate of patients. However, the occurrence and development of PCa is a complex biological process, ...

Emerging biomarkers in the diagnosis of prostate cancer

New promising biomarkers, such as PSA glycoforms, TMPRSS2:ERG fusion gene, microRNAs, circulating tumor cells, androgen receptor variants, ...

Emerging biomarkers of prostate cancer (Review)

PSA is a protein produced only by prostate tissue and would seem to be an ideal marker for prostatic disease. However, serum tPSA variability ...

Emerging biomarkers in the detection and prognosis of prostate ...

Abstract: The prostate-specific antigen (PSA) is currently the most used tumor marker in the early detection of the.

Emerging biomarkers for prostate cancer diagnosis, staging, and ...

Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis. Review uri icon. scroll to property group menus. Overview. abstract. The introduction ...

Biomarkers for Prostate Cancer: From Diagnosis to Treatment - MDPI

Urinary miRNAs have emerged as promising biomarkers for detecting prostate cancer (PCa), offering valuable tools to distinguish between malignant and benign ...

Emerging Molecular Biomarkers in Advanced Prostate Cancer

Primary prostate cancer is commonly multifocal at the time of diagnosis. It has a long natural history with often 5 years or more before distant metastases are ...

Emerging biomarkers for the diagnosis and prognosis of prostate ...

It is hoped that the use of panels of markers can improve CaP diagnosis and prognosis and help predict the therapeutic response in CaP patients.

Liquid Biomarkers in Prostate Cancer Diagnosis

Emerging biomarkers, including non-coding RNAs, circulating tumor DNA, and prostate-specific antigen (PSA) glycosylation, offer valuable ...

Emerging biomarkers in the detection and prognosis of prostate ...

New biomarkers, including urine prostate cancer gene 3 (PCA3) score, Prostate Health Index (PHI), and the four-kallikrein panel, have been investigated during ...

Emerging Biomarker-Guided Therapies in Prostate Cancer - MDPI

With the advancement of molecular sequencing techniques, genomic precision through the identification of potential treatment targets and predictive biomarkers ...